… liverdisease in Europe continues to grow. We aimed to describe the epidemiology of liver diseases … these risk factors to reduce the burden of liverdisease. As part of the HEPAHEALTH …
J Xiao, F Wang, NK Wong, J He, R Zhang, R Sun… - Journal of …, 2019 - Elsevier
… By adopting a comparative viewpoint, we also discuss China’s strategic areas of hepatological research, funding trends, institutional centres and drug development for …
… level, this analysis of non-invasive strategies is a strength of … two-step approach for NAFLD risk stratification and highlights … analyze risk stratification strategies for patients with NAFLD …
… This analysis evaluated the cost effectiveness of a comprehensive list of screening strategies for a cirrhosis diagnosis in the context of NAFLD with a varying prevalence of cirrhosis. …
M Garrido-Estepa, P Latasa… - European Journal of …, 2021 - journals.lww.com
… previous period and not together with 2016–2017, when the strategic plan was starting. However, tables and analysis pretend to show the decrease in the hospital rates after treatment …
… fatty livers or in palmitate‐stimulated primary hepatocytes, suggesting that the up‐regulated TRIM8 protein level in fattyliver … expression in livers of nonalcoholic fattyliverdisease/NASH …
… Such a strategy involves an initial screening with a liver chemistry panel and an abdominal … elevated liver chemistries requires a detailed analysis of additional etiologies of liverdisease…
YC Zhang, ZY Lyu, B Ma, LM Li, W Wang… - Hepatology …, 2022 - Springer
… In the present analysis, we first classified all participants into the following three groups based on FLD and MAFLD status: FLD( − ), MAFLD( − ), and MAFLD( +). Then, by incorporating …
G Targher, CD Byrne, A Lonardo, G Zoppini… - Journal of …, 2016 - Elsevier
… However, before this clinical practice strategy can be … meta-analysis of observational studies indicate that NAFLD is … liverdisease. Some uncertainty, however, remains as to whether …